Patent · US Active

Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections

US9161934B2 · kind B2 · utility

23Cited by
12References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 12, 2015
Grant dateOct 20, 2015
Priority date—
Expiry dateJan 12, 2035

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application includes novel modulators of TLRs, compositions containing such compounds, therapeutic methods that include the administration of such compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.